$BX Blackstone Group Inc Insider Trading
Get free email notifications about insider trading in Blackstone Group Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Blackstone Group Inc. Insider overview, share value development, latest insider transactions and email notifications about new events in Blackstone Group Inc for free.
CIK Number: 0001393818
Industry: INVESTMENT ADVICE [6282]
Trading Symbol: BX
Company Address: 345 PARK AVENUE NEW YORK 10154
Former name: Blackstone Group L.P., date of change: 2007-03-20
Market Capitalization: $19.27B
Prev close: $30.55
Average Daily Volume: 5,473,100
Days Low: $30.17
Year Low: $22.45
Year High: $31.69
Blackstone Group Inc Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 16 2021 | BX | Blackstone Group I ... | Blackstone Group Inc | 10% Owner | Sell | S | 25.38 | 5,175,000 | 131,341,500 | 19,037,042 | 24.2 M to 19 M (-21.37 %) |
Jun 08 2021 | BX | Blackstone Group I ... | 313 Acquisition LLC | 10% Owner | Sell | J | 0.00 | 153,213 | 0 | 104,536,629 | 104.7 M to 104.5 M (-0.15 %) |
May 14 2021 | BX | Blackstone Group I ... | Ayotte Kelly | Director | Grant | A | 0.00 | 2,462 | 0 | 11,989 | 9.5 K to 12 K (+25.84 %) |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 135,334 | 0 | 0 | |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 676,774 | 0 | 0 | |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 366,918 | 0 | 0 | |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 562,891 | 0 | 0 | |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 278,707 | 0 | 0 | |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 696,767 | 0 | 0 | |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 717,160 | 0 | 0 | |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,586,364 | 0 | 0 | |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,944,371 | 0 | 0 | |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,982,874 | 0 | 0 | |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,476,924 | 0 | 0 | |
May 14 2021 | BX | Blackstone Group I ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,692,307 | 0 | 0 |